Abstract:Objective To investigate the correlation of plasma matrix metaUoproteinase-3 （MMP-3） levels and MMP-3 Lys45Glu （rs679620） polymorphism with ischemic stroke and its TOAST subtypes. Methods The patients with large artery atherosclerotic stroke （LAA） and small artery occlusion stroke （SAO） according to TOAST etiological typing （ischemic stroke goup） and healthy subjects （control group） were enrolled. The enzyme-linked immunosorbent assay was used to detect plasma MMP-3 level. The polymerase chain reaction-restriction fragment length polymorpbism （PCR-RFLP） was used to detect the genotypes of MMP-3 Lys45Glu. Results A total of 233 patients with ischemic stroke were enrolled, in which 162 were LAA and 71 were SAO; 200 healthy subjects were taken as controls. The plasma MMP-3 level in the ischemic stroke group was significantly higher than that in the control group （253.99 ± 75.02 ng/ml vs. 196. 38 ± 78. 17 ng/ml; t =7. 813, P =0. 000）. The plasma MMP-3 level in the LAA group （262. 81 ±69. 23 ng/ml） was significantly higher than those in the groups of SAO （233.85 ± 83.90 ng/ml, P = 0. 008） and control （P = 0. 000）, and the plasma MMP-3 level in the SAO was also significantly higher than that in the control group （P = 0. 000）. Multivariate logistic regression analysis showed that the increased serum MMP-3 level was an independent risk factor for ischemic stroke （odds ratio [ OR] 1. 012, 95% confidence interval [ CI] 1. 008 - 1. 015; P =0. 000）. There was no sigrtificant difference in the frequencies of genotype （X2 = 2. 085, P =0. 353） and allele （X^2 = 2. 29, P =0. 130） of MMP-3 Lys45Glu between the ischemic stroke group and the control group. However, there were significant difference in MMP-3 Lys45Glu genotype frequencies among the groups of LAA, SAO and control （X^2 = 10.39,P=0.034）. The AA ＋GA genotype frequency in the LAA group was significant higher than those in the groups of SAO （65.4% vs. 49. 3% ;X^2 =5. 375, P =0. 020） and control （65.4% vs. 54. 0% ;X^2 =4. 84, P =0. 028）. There was no significant difference in the allele frequencies among the groups of LAA, SAO and control （X^2 =3. 887, P =0. 143）. Multivariate logistic regression analysis showed that MMP-3 Lys45Glu polymorphism was an independent risk factor for LAA （OR 1. 783, 95% CI 1. 183 - 2. 688; P = 0. 006）. The plasma MMP-3 level in patients with the genotypes AA （n =73）, GA （n = 176） and GG （n = 184） were 235. 70 ± 70. 85 ng/ml, （244. 20 ± 85. 90 ng/ml and 207. 98 ± 77. 61 ng/ml. There were significant difference in the plasma MMP-3 levels among the patients with the gmotypes AA, GA and GG （F =9. 682, P = 0. 000）. The plasma MMP-3 level in the patients with the genotype AA ＋ GA was significantly higher than that in patients with genotype GG （241.71 -± 81.73 ng/ml vs. 207. 98 ± 77. 61 ng/ml; t = 4. 336, P = 0. 000）. Conclusions The plasma MMP-3 level increased in patients with LAA or SAO, especially in the patients with LAA. The MMP-3 Lys45Glu polymorphism might be associated with the plasma MMP-3 level and LAA. Key words: Matrix MetaUoproteinase 3; Polymorphism, Genetic; Stroke; Brain Ischemia

Correlations among the serum levels of matrix metalloproteinase-9 and its gene C1562T polymorphism and the stability of carotid arteriosclerotic plaque in Uygur patients with cerebral infarction

Relationship Between Matrix Metalloproteinase-9 and Tissue Metalloproteinase Inhibitor-1 and Carotid Atheromatous Plaque Stability

The Marker of Unstable Carotid Atheromatous Plaque in Cerebral Infarction Patients

A Study of the Relationship Between Carotid Artery Arteriosclerosis in Patients with Cerebral Stroke and Angiotensin Converting Enzyme Gene Polymorphism and Blood Lipids

Association between phosphodiesterase 4D gene polymorphism and carotid atherosclerosis in patients with cerebral infarction

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

The Relationship Between Angiotensin Converting Enzyme Gene Polymorphism and Cerebral Stroke

Relation of Metalloproteinase 9 and Its Inhibitor with Carotid Artery Atherosclerosis in Aged Patients with Hypertension

Variations in Matrix Metalloproteinase-1, -3, and -9 Genes and the Risk of Acute Coronary Syndrome and Coronary Artery Disease in the Chinese Han Population.

The Study of Relationship Between Leukotriene B4(LT-B4) ,matrix Metallopeptidase 9 (MMP-9) and Stability of Carotid Plaques

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

The Relationship Between Polymorphism of Interleukin-1Αc-889t and Patients with Coronary Heart Disease

Correlation Between Lys45 Glu Polymolphism of Matrix Metalloproteinase-3 and Ischenic Stroke Subtypes

Study on correlation between OCT for detecting characteristics of coronary artery plaque and matrix metalloproteinase

Association analysis between MMP-8-799C/T polymorphism and the risk of myocardial infarction

Study on Atherosclerotic Plaque Composition in Patients with Intermediate Coronary Stenosis by Multidetector Computed Tomography Angiography,serum Matrix Metalloproteinase 9 and Soluble CD40 Ligand

Correlation between matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 and white matter hyperintensities in patients with cerebral small vessel disease based on cranial magnetic resonance 3D imaging

Study on correlation between levels of hs-CRP, IL-6 and MMP-9 with cerebral microbleeding

Correlations of serum cystatin C level and gene polymorphism with vascular cognitive impairment after acute cerebral infarction

Correlation of Matrix Metalloproteinase-2 Single Nucleotide Polymorphisms with the Risk of Small Vessel Disease (SVD)

Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population